EPIRUS Biopharmaceuticals (EPRSQ) 10-Q 2013 Q3 Quarterly report

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal executive officer and principal financial officer of Zalicus Inc. (the “Company”), do hereby certify that to their knowledge:

1) the Company’s Form 10-Q for the fiscal quarter ended September 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) the information contained in the Company’s Form 10-Q for the fiscal quarter ended September 30, 2013 fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Mark H. N. Corrigan

Mark H. N. Corrigan

President and Chief Executive Officer

(principal executive officer)

/s/ Justin A. Renz

Justin A. Renz

Executive Vice President and Chief Financial Officer

(principal financial officer)

Dated: November 4, 2013